SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Drug Development
Manhattan Pharmaceuticals, Inc. Expanding Oral Oleoyl-estrone Clinical Program To Include Morbidly Obese
October 12, 2006
 · 
5 min read
Pharm Country
Manhattan Pharmaceuticals, Inc.’ Alan G. Harris, MD, PhD To Chair Metabolic Syndrome Conference
September 19, 2006
 · 
1 min read
Pharm Country
Manhattan Pharmaceuticals, Inc. To Present At Oppenheimer 2nd Annual Diabetes Investment Conference
September 14, 2006
 · 
1 min read
Pharm Country
Manhattan Pharmaceuticals, Inc. To Present At Roth Capital Partners 2006 New York Conference
August 30, 2006
 · 
1 min read
Pharm Country
Manhattan Pharmaceuticals, Inc. To Present At 2nd Annual Obesity Drug Development Summit
July 19, 2006
 · 
1 min read
Business
Manhattan Pharmaceuticals, Inc. Names Michael G. McGuinness As Chief Financial Officer
July 10, 2006
 · 
1 min read
Drug Development
Manhattan Pharmaceuticals, Inc. Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug Candidate
June 29, 2006
 · 
4 min read
Pharm Country
Manhattan Pharmaceuticals, Inc. To Present At Friedman Billings Ramsey 2006 Growth Investor Conference
May 24, 2006
 · 
1 min read
Drug Development
Manhattan Pharmaceuticals, Inc. Receives Swissmedic’s Approval To Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
May 16, 2006
 · 
4 min read
Drug Development
Manhattan Pharmaceuticals, Inc. Reports Update On Clinical Development Programs
April 28, 2006
 · 
1 min read
Business
Manhattan Pharmaceuticals, Inc. Names Alan Harris Chief Medical Officer
February 1, 2006
 · 
1 min read
Drug Development
Manhattan Pharmaceuticals, Inc.'s Topical Psoriasis Treatment In Phase IIa Trial
December 28, 2005
 · 
5 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS